Vegetable Staticks by Stephen Hales 2026-10-31
Original experiments by Stephen Hales on plant perspiration and sap pressure. Chapter III, pp. 100–103, describes the vine experiments; the scanned copy at darwin-online.org.uk/converted/pdf/1827_Hales_Vegetable_staticks_A4453.pdf reproduces these pages.
Haemosiderin Created 2026-10-31 Updated 2026-11-05
Nasopharynx Created 2026-10-31 Updated 2026-11-05
The nasopharynx is the upper part of the pharynx behind the nasal cavity and above the soft palate. The auditory tubes open into it. This anatomical connection links middle-ear pressure regulation to the upper respiratory passage.
British Pharmacopoeia (1867) 2026-10-31
Published under the direction of the General Council of Medical Education and Registration of the United Kingdom. This is the contemporary 1867 edition, not a modern pharmacopoeial recipe. The title, publisher and year are verified by the scan catalogue: commons.wikimedia.org/wiki/File:British_pharmacop%C5%93ia,_1867_(electronic_resource)_(IA_b21687298).pdf.
Inspected text: upload.wikimedia.org/wikipedia/commons/a/ae/British_pharmacopoeia_-_1867_%28IA_b21695180%29.pdf. Printed pp. 13–14, Acidum Hydrocyanicum Dilutum: identity, two-percent strength, mixed iron-salt test and silver assays. Printed p. 65, Calx Chlorata: production, appearance and useful oxidizing strength.
Institutional emergency-response information. Cited sections: Agent Characteristics, odour and exposure hazards. Used only to qualify the historical analytical account.
Public-domain primary source: London, Spottiswoode, 1867. The linked edition is the original 1867 issue; the additions of 1874 are not included.
Cyanide chemical fact sheet by CDC 2026-10-31
Background: impairment of oxygen use. Used for mechanism only.
Public-domain contemporary notice, July 1867, volume 13, issue 1, p. 99. Records the three Gazette notices of 14 June 1867.
FDA multidisciplinary review of YCANTH 2026-10-31
NDA 212905, §5.3, Primary pharmacology, p. 32. Describes cantharidin as a vesicant and the associated acantholysis.
YCANTH prescribing information 2026-10-31
Polyethylene Glycol 3350 by MedlinePlus 2026-10-31
“Why is this medication prescribed?” describes osmotic retention of water in stool.
PegLyte prescribing information 2026-10-31
Health Canada regulatory product information, “Action and clinical pharmacology”, p. 9: local osmotic mechanism and minimal absorption of polyethylene glycol 3350.
Chemical fact sheet; “How it works” and “Signs and symptoms”.
Clinical case discussion; questions 1–3 explain glycine receptor action and comparison with tetanus.
Official account of sources, symptoms and the odourless character of carbon monoxide.
There are unlisted articles, also show them or only show them.